Chi-Yi Chen Selected Research

Ribavirin (Virazole)

11/2022	A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C.
1/2022	Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
10/2021	Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis.
10/2021	Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
1/2021	Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
1/2020	Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
8/2018	Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
6/2009	Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2b.
3/2003	High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-Yi Chen Research Topics

Disease

23	Chronic Hepatitis C 04/2024 - 03/2003
20	Infections 05/2024 - 03/2003
17	Fibrosis (Cirrhosis) 04/2024 - 01/2014
17	Chronic Hepatitis B 03/2024 - 06/2007
16	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 04/2015
14	Neoplasms (Cancer) 04/2024 - 11/2010
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 12/2012
6	Liver Diseases (Liver Disease) 04/2024 - 04/2021
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 10/2016
5	Diabetes Mellitus 04/2024 - 01/2020
5	Liver Neoplasms (Liver Cancer) 04/2024 - 05/2012
5	Hepatitis C 01/2024 - 03/2014
4	Virus Diseases (Viral Diseases) 04/2023 - 04/2021
4	Viremia 04/2022 - 03/2003
3	Hemorrhage 01/2023 - 12/2012
3	Coinfection 04/2022 - 10/2021
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2024
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2023
2	Hepatitis B 11/2023 - 04/2022
2	Obesity 10/2023 - 01/2023
2	Fever (Fevers) 11/2022 - 10/2021
2	Headache (Headaches) 11/2022 - 11/2016
2	Carcinogenesis 01/2022 - 11/2021
2	Disease Progression 01/2021 - 12/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2010
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 11/2016
2	Nasopharyngitis 01/2020 - 11/2016
2	Lung Neoplasms (Lung Cancer) 05/2016 - 11/2010
1	Communicable Diseases (Infectious Diseases) 01/2024
1	Overweight 10/2023
1	Hyperbilirubinemia 04/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022
1	Adenocarcinoma 12/2022

Drug/Important Bio-Agent (IBA)

25	Antiviral Agents (Antivirals)IBA 05/2024 - 12/2016
13	InterferonsIBA 11/2022 - 01/2014
11	entecavir FDA Link 01/2024 - 01/2014
10	Tenofovir (Viread)FDA Link 01/2024 - 11/2016
9	SofosbuvirIBA 01/2024 - 01/2018
9	Ribavirin (Virazole)FDA LinkGeneric 11/2022 - 03/2003
6	Hepatitis B e AntigensIBA 03/2024 - 06/2007
6	velpatasvirIBA 01/2024 - 12/2018
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2010
5	Messenger RNA (mRNA)IBA 01/2020 - 12/2013
4	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
4	Alanine Transaminase (SGPT)IBA 04/2024 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 01/2024 - 06/2019
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2012
3	tenofovir alafenamideIBA 10/2023 - 11/2016
3	BilirubinIBA 04/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2020
3	CateninsIBA 10/2020 - 10/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2023
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2023
2	Clarithromycin (Biaxin)FDA LinkGeneric 01/2023 - 09/2006
2	AlbuminsIBA 01/2023 - 01/2020
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2023 - 09/2006
2	Esomeprazole (Nexium)FDA Link 01/2023 - 09/2006
2	BismuthIBA 01/2023 - 11/2016
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2023 - 07/2009
2	AntigensIBA 12/2022 - 04/2022
2	peginterferon alfa-2b (Pegintron)FDA Link 11/2022 - 06/2009
2	sofosbuvir drug combination ledipasvirIBA 08/2022 - 12/2018
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2020
2	EnzymesIBA 01/2022 - 05/2012
2	daclatasvirIBA 01/2021 - 12/2018
2	asunaprevirIBA 01/2021 - 12/2018
2	Cyproheptadine (Periactin)FDA Link 01/2021 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 04/2019 - 12/2013
2	Ritonavir (Norvir)FDA Link 12/2018 - 08/2018
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 11/2017
2	NucleosidesIBA 01/2018 - 01/2014
2	NucleotidesIBA 01/2018 - 01/2014
2	Lamivudine (Epivir)FDA Link 01/2018 - 01/2014
2	Oncogene Proteins (Oncogene Protein)IBA 05/2016 - 11/2010
2	Interferon-alpha (Interferon Alfa)IBA 03/2014 - 03/2003
2	ArsenicIBA 11/2013 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 11/2010
1	A-factor (Streptomyces)IBA 01/2024
1	HDL LipoproteinsIBA 10/2023
1	CholesterolIBA 10/2023
1	LipidsIBA 10/2023
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 04/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2023
1	Metronidazole (Metric)FDA LinkGeneric 01/2023
1	Levofloxacin (Levaquin)FDA Link 01/2023
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 01/2023
1	bismuth tripotassium dicitrate (bismuth subcitrate)IBA 01/2023
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 12/2022
1	CarbohydratesIBA 12/2022
1	Tumor Biomarkers (Tumor Markers)IBA 12/2022
1	Lipase (Acid Lipase)FDA Link 12/2022
1	Amylases FDA Link 12/2022

Therapy/Procedure

29	Therapeutics 04/2024 - 03/2003
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
2	Liver Transplantation 01/2018 - 07/2009